|
US6458772B1
(en)
|
1909-10-07 |
2002-10-01 |
Medivir Ab |
Prodrugs
|
|
DE852392C
(de)
|
1944-08-30 |
1952-10-13 |
Hoechst Ag |
Verfahren zur Darstellung von Selencyanverbindungen bzw. Selenazolen von aromatischen Aminen
|
|
FR2492258A1
(fr)
|
1980-10-17 |
1982-04-23 |
Pharmindustrie |
Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
|
|
ES2061442T3
(es)
|
1985-10-14 |
1994-12-16 |
Nippon Zoki Pharmaceutical Co |
Peptidos.
|
|
FR2662695A1
(fr)
|
1990-06-05 |
1991-12-06 |
Rhone Poulenc Sante |
Amino-2 polyfluoroalcoxy-6 benzoselenazoles, leur preparation et les medicaments les contenant.
|
|
FR2699077B1
(fr)
|
1992-12-16 |
1995-01-13 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
|
|
IT1266565B1
(it)
|
1993-07-22 |
1997-01-09 |
Ct Lab Farm Srl |
Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
|
|
WO1999051613A1
(en)
|
1998-04-03 |
1999-10-14 |
Medivir Ab |
Prodrugs of phosphorous-containing pharmaceuticals
|
|
WO2001019321A2
(en)
|
1999-09-15 |
2001-03-22 |
Elan Pharmaceuticals, Inc. |
Methods for treating neuropathic pain using hetreoarylmethanesulfonamides
|
|
GB0002952D0
(en)
|
2000-02-09 |
2000-03-29 |
Pharma Mar Sa |
Process for producing kahalalide F compounds
|
|
FR2824477B1
(fr)
*
|
2001-05-09 |
2005-09-09 |
Ethypharm Lab Prod Ethiques |
Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes
|
|
JP2004059452A
(ja)
|
2002-07-25 |
2004-02-26 |
Asahi Glass Co Ltd |
ペンタフルオロサルファー置換ベンズイミダゾール化合物およびその製造方法
|
|
EP1610797A1
(en)
|
2003-03-27 |
2006-01-04 |
Boehringer Ingelheim International GmbH |
Antiviral combination of nevirapine and a further antiretroviral compound
|
|
KR101148734B1
(ko)
*
|
2003-10-10 |
2012-07-05 |
에띠빠흠 |
징코 빌로바 추출물을 포함하는 서방형 미세과립 및 이것을 제조하는 방법
|
|
UA83416C2
(en)
|
2004-02-13 |
2008-07-10 |
Баниу Фармасьютикал Ко., Лтд. |
Fused ring 4-oxopyrimidine derivative
|
|
MY144903A
(en)
|
2004-06-17 |
2011-11-30 |
Novartis Ag |
Pyrrolopyridine derivatives and their use as crth2 antagonists
|
|
EP1621187A1
(en)
*
|
2004-07-26 |
2006-02-01 |
AstraZeneca AB |
Pharmaceutical multiparticulate tablet formulations and process for their preparation
|
|
US8193211B2
(en)
|
2004-09-30 |
2012-06-05 |
Supernus Pharmaceuticals, Inc. |
Controlled release compositions of gamma-hydroxybutyrate
|
|
WO2006038226A2
(en)
*
|
2004-10-08 |
2006-04-13 |
Rubicon Research Pvt. Ltd. |
Process for making a highly compressible controlled delivery compositions of metformin
|
|
EP1679076A1
(en)
|
2005-01-06 |
2006-07-12 |
Medivir Ab |
Compounds useful in the treatment of HIV
|
|
US20080175873A1
(en)
|
2005-06-02 |
2008-07-24 |
Biovail Laboratories International S.R.L. |
Modified release composition of at least one form of venlafaxine
|
|
US7960561B2
(en)
|
2005-06-21 |
2011-06-14 |
Neurosearch A/S |
2-(phenylamino) benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
|
|
US20070134315A1
(en)
*
|
2005-12-08 |
2007-06-14 |
Viera Michael L |
Orally administrable extended release pellet and tablet formulations of a highly water soluble compound
|
|
EP2051735B1
(en)
|
2006-07-17 |
2012-08-29 |
Ramot, at Tel Aviv University Ltd. |
Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use treating pain and other cns disorders
|
|
ITTO20070665A1
(it)
|
2007-09-24 |
2009-03-25 |
Rottapharm Spa |
Derivati amidinici, tioureici e guanidinici di 2-amminobenzotiazoli e amminobenzotiazine, nuovi agenti farmacologici per il trattamento delle patologie neurodegenerative.
|
|
EP2268281A4
(en)
|
2008-02-15 |
2012-05-02 |
Abbott Lab |
THIENOPYRROLES AND PYRROLOTHIAZOLES AS NEW THERAPEUTIC AGENTS
|
|
LT2278975T
(lt)
|
2008-05-07 |
2016-11-25 |
Cardioxyl Pharmaceuticals Inc. |
Nauji nitrozo junginiai kaip nitroksilo donorai, ir jų panaudojimo būdas
|
|
US8778398B2
(en)
*
|
2008-11-04 |
2014-07-15 |
Jazz Pharmaceuticals, Inc. |
Immediate release formulations and dosage forms of gamma-hydroxybutyrate
|
|
FR2938431B1
(fr)
*
|
2008-11-14 |
2013-12-20 |
Debregeas Et Associes Pharma |
Nouvelle composition a base d'acide gamma-hydroxybutyrique
|
|
CA2759251C
(en)
|
2009-04-23 |
2017-01-03 |
Concert Pharmaceuticals, Inc. |
4-hydroxybutyric acid analogs
|
|
KR101632318B1
(ko)
|
2009-11-05 |
2016-06-27 |
재단법인 의약바이오컨버젼스연구단 |
벤조헤테로사이클 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 암 예방 및 치료용 조성물
|
|
WO2011084846A1
(en)
|
2010-01-07 |
2011-07-14 |
Alkermes, Inc. |
Quaternary ammonium salt prodrugs
|
|
MX391660B
(es)
|
2010-03-24 |
2025-03-21 |
Jazz Pharmaceuticals Inc |
Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas
|
|
CN102946869B
(zh)
*
|
2010-05-04 |
2016-08-03 |
爵士制药有限公司 |
γ-羟基丁酸的速释制剂及剂型
|
|
FR2971422B1
(fr)
|
2011-02-11 |
2016-05-20 |
Debregeas Et Associes Pharma |
Granules d'acide gamma-hydroxybutyrique
|
|
ES2804540T3
(es)
|
2011-02-14 |
2021-02-08 |
Concert Pharmaceuticals Inc |
Análogos deuterados de ácido 4hidroxibutírico
|
|
US9428490B2
(en)
|
2011-07-29 |
2016-08-30 |
Karyopharm Therapeutics Inc. |
Nuclear transport modulators and uses thereof
|
|
WO2013163244A1
(en)
|
2012-04-26 |
2013-10-31 |
Bristol-Myers Squibb Company |
Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
|
|
US20150210624A1
(en)
|
2012-08-22 |
2015-07-30 |
Concert Pharmaceuticals, Inc. |
Deuterated 4-hydroxybutyric acid analogs
|
|
US20160068463A1
(en)
|
2012-11-14 |
2016-03-10 |
Metabolix, Inc. |
Production of salts of 4-hydroxybutyrate using biobased raw materials
|
|
US20160016916A1
(en)
|
2013-03-15 |
2016-01-21 |
Karyopharm Therapeutics Inc. |
Exo Olefin-Containing Nuclear Transport Modulators and Uses Thereof
|
|
WO2014205393A1
(en)
|
2013-06-21 |
2014-12-24 |
Karyopharm Therapeutics Inc. |
Nuclear transport modulators and uses thereof
|
|
WO2015057884A1
(en)
|
2013-10-16 |
2015-04-23 |
The Regents Of The University Of California |
Methods for treating seizure disorders and pain
|
|
ITMI20132041A1
(it)
|
2013-12-06 |
2015-06-07 |
Ct Lab Farm Srl |
Derivati dell'acido gamma-idrossibutirrico, loro preparazione e loro uso medico.
|
|
US10398662B1
(en)
*
|
2015-02-18 |
2019-09-03 |
Jazz Pharma Ireland Limited |
GHB formulation and method for its manufacture
|
|
WO2017049470A1
(en)
|
2015-09-23 |
2017-03-30 |
Xw Laboratories Inc. |
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
|
|
CN113061089A
(zh)
|
2015-09-23 |
2021-07-02 |
凯瑞康宁生物工程（武汉）有限公司 |
γ-羟基丁酸的前药及其组合物和用途
|
|
UY37341A
(es)
|
2016-07-22 |
2017-11-30 |
Flamel Ireland Ltd |
Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
|
|
US11602530B2
(en)
|
2016-11-28 |
2023-03-14 |
Biogen Ma Inc. |
CRM1 inhibitors for treating epilepsy
|
|
EA201992116A1
(ru)
|
2017-03-08 |
2020-01-29 |
СИНРКС ФАРМА, ЭлЭлСи |
Фармацевтические составы флороглюцинола и триметилфлороглюцинола
|
|
JP7349428B2
(ja)
|
2017-12-20 |
2023-09-22 |
フラメル アイルランド リミテッド |
改善された安定性を有するパッケージされた修飾放出ガンマ－ヒドロキシブチラート製剤
|
|
CN113473980A
(zh)
|
2019-03-01 |
2021-10-01 |
弗拉梅尔爱尔兰有限公司 |
在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物
|
|
CN116261451A
(zh)
|
2020-07-24 |
2023-06-13 |
凯瑞康宁生物工程有限公司 |
γ-羟基丁酸衍生物的药物组合物和药物动力学
|